Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/30/2015
Local Institution
mi
from
Calgary,
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/30/2015
Local Institution
mi
from
Calgary,
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Clinical Research Advantage / Desert Clinical Res, Llc
mi
from
Tempe, AZ
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Clinical Research Advantage / Desert Clinical Res, Llc
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Medical Group Of Encino
mi
from
Encino, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Medical Group Of Encino
mi
from
Encino, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Valley Research
mi
from
Fresno, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Valley Research
mi
from
Fresno, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Randall Shue, D.O.
mi
from
Los Angeles, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Randall Shue, D.O.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Diabetes Medical Center Of California
mi
from
Northridge, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Diabetes Medical Center Of California
mi
from
Northridge, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Ritchken and First MD's
mi
from
San Diego, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Ritchken and First MD's
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Encompass Clinical Research
mi
from
Spring Valley, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Raikhel, Marina
mi
from
Torrance, CA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Raikhel, Marina
mi
from
Torrance, CA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Express Care Clinical Res
mi
from
Colorado Springs, CO
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Express Care Clinical Res
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Denver Internal Medicine
mi
from
Denver, CO
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Denver Internal Medicine
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
New West Physicians
mi
from
Golden, CO
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
New West Physicians
mi
from
Golden, CO
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Central Florida Clinical Trials
mi
from
Altamonte Springs, FL
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Central Florida Clinical Trials
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Family Care Associates Of Nw Florida
mi
from
Chipley, FL
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Family Care Associates Of Nw Florida
mi
from
Chipley, FL
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Health Partners Research Foundation
mi
from
Minneapolis, MN
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Health Partners Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Woodlake Research
mi
from
Chesterfield, MO
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Woodlake Research
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Newark Physician Associates
mi
from
Newark, OH
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Newark Physician Associates
mi
from
Newark, OH
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Integris Family Care S. Penn
mi
from
Oklahoma City, OK
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Integris Family Care S. Penn
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Cumberland Valley Endocrinology Center, Llc
mi
from
Carlisle, PA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Cumberland Valley Endocrinology Center, Llc
mi
from
Carlisle, PA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Banksville Medical Pc
mi
from
Pittsburgh, PA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Banksville Medical Pc
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Palmetto Clinical Research
mi
from
Summerville, SC
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Palmetto Clinical Research
mi
from
Summerville, SC
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Southeastern Research Assoc
mi
from
Taylors, SC
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Southeastern Research Assoc
mi
from
Taylors, SC
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
'Diabetes & Glandular Disease Research Associates, P.A.
mi
from
San Antonio, TX
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
'Diabetes & Glandular Disease Research Associates, P.A.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
SAM Clinical Research Center
mi
from
San Antonio, TX
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
SAM Clinical Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Optimum Clinical Research
mi
from
Salt Lake City, UT
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Optimum Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Office Of Dr. Gray
mi
from
Spokane, WA
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Office Of Dr. Gray
mi
from
Spokane, WA
Click here to add this to my saved trials
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated:  9/30/2015
Local Institution
mi
from
Capital Federal,
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Status: Enrolling
Updated: 9/30/2015
Local Institution
mi
from
Capital Federal,
Click here to add this to my saved trials
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated:  10/1/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 10/1/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated:  10/1/2015
Metropolitan Asian Family Services
mi
from
Chicago, IL
Translating a Heart Disease Lifestyle Intervention Into the Community
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 10/1/2015
Metropolitan Asian Family Services
mi
from
Chicago, IL
Click here to add this to my saved trials
Validation of an RLIP76 Assay in Humans
Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome
Status: Enrolling
Updated:  10/1/2015
City of Hope Medical Center
mi
from
Duarte, CA
Validation of an RLIP76 Assay in Humans
Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome
Status: Enrolling
Updated: 10/1/2015
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
A Pharmacodynamic Comparison of Prasugrel vs. Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Status: Enrolling
Updated:  10/1/2015
University of Florida
mi
from
Jacksonville, FL
Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
A Pharmacodynamic Comparison of Prasugrel vs. Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Status: Enrolling
Updated: 10/1/2015
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
TEAMcare for Diabetes in Mental Health Centers
A Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia
Status: Enrolling
Updated:  10/1/2015
Harborview Medical Center
mi
from
Seattle, WA
TEAMcare for Diabetes in Mental Health Centers
A Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia
Status: Enrolling
Updated: 10/1/2015
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Long Term Health Outcomes of Women Veterans' Service During the Vietnam Era
CSP #579 - Long Term Health Outcomes of Women's Service During the Vietnam Era
Status: Enrolling
Updated:  10/2/2015
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Long Term Health Outcomes of Women Veterans' Service During the Vietnam Era
CSP #579 - Long Term Health Outcomes of Women's Service During the Vietnam Era
Status: Enrolling
Updated: 10/2/2015
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Continuous Glucose Monitoring to Measure Effect of Glycemic Index
The Effect of Glycemic Index on Post-prandial Glycemia (Breakfast vs. Lunch) in Patients With Type 1 Diabetes: Quantification With Continuous Glucose Monitoring
Status: Enrolling
Updated:  10/2/2015
Legacy Health System--Holladay Park Campus
mi
from
Portland, OR
Continuous Glucose Monitoring to Measure Effect of Glycemic Index
The Effect of Glycemic Index on Post-prandial Glycemia (Breakfast vs. Lunch) in Patients With Type 1 Diabetes: Quantification With Continuous Glucose Monitoring
Status: Enrolling
Updated: 10/2/2015
Legacy Health System--Holladay Park Campus
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Glycemic Control on Liver Transplantation Outcomes
Prospective, Randomized, Open-Label, Controlled Study to Evaluate the Safety and Efficacy of Intensive Glycemic Control on Outcomes Following Liver Transplantation
Status: Enrolling
Updated:  10/5/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Study of Glycemic Control on Liver Transplantation Outcomes
Prospective, Randomized, Open-Label, Controlled Study to Evaluate the Safety and Efficacy of Intensive Glycemic Control on Outcomes Following Liver Transplantation
Status: Enrolling
Updated: 10/5/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1
Status: Enrolling
Updated:  10/5/2015
Vanderbilt University- General Clinic Research Center
mi
from
Nashville, TN
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1
Status: Enrolling
Updated: 10/5/2015
Vanderbilt University- General Clinic Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  10/6/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 10/6/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Phase II, Double Blind, Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Atorvastatin in Subjects With Newly Diagnosed Type 1 Diabetes Mellitus.
Status: Enrolling
Updated:  10/7/2015
Diabetes Center for Children & Clinical Translational Research Center
mi
from
Philadelphia, PA
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Phase II, Double Blind, Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Atorvastatin in Subjects With Newly Diagnosed Type 1 Diabetes Mellitus.
Status: Enrolling
Updated: 10/7/2015
Diabetes Center for Children & Clinical Translational Research Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Christus Memorial Hospital
mi
from
Corpus Christi, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Christus Memorial Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Valley Baptist Family Medicine Residency Program
mi
from
Harlingen, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Valley Baptist Family Medicine Residency Program
mi
from
Harlingen, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Laredo Medical Group
mi
from
Laredo, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Laredo Medical Group
mi
from
Laredo, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
McAllen Family Medicine Residency Program
mi
from
McAllen, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
McAllen Family Medicine Residency Program
mi
from
McAllen, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Family Medicine Residency Program, Christus Santa Rosa Hospital
mi
from
San Antonio, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Family Medicine Residency Program, Christus Santa Rosa Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated:  10/7/2015
Dept Family & Community Medicine, UTHSCSA
mi
from
San Antonio, TX
A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas
An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
Status: Enrolling
Updated: 10/7/2015
Dept Family & Community Medicine, UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus
Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus: A Feasibility Cohort Study
Status: Enrolling
Updated:  10/7/2015
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus
Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus: A Feasibility Cohort Study
Status: Enrolling
Updated: 10/7/2015
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
A Phase III Randomised, Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 10773 Compared to Glimepiride Administered Orally During 104 Weeks With a 104 Week Extension Period in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Metformin Treatment
Status: Enrolling
Updated:  10/8/2015
205.452.01283 Boehringer Ingelheim Investigational Site
mi
from
Phoenix, AZ
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
A Phase III Randomised, Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 10773 Compared to Glimepiride Administered Orally During 104 Weeks With a 104 Week Extension Period in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Metformin Treatment
Status: Enrolling
Updated: 10/8/2015
205.452.01283 Boehringer Ingelheim Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials